CERo Therapeutics (CERO) Insider Trading & Ownership $2.31 -0.03 (-1.28%) Closing price 04:00 PM EasternExtended Trading$2.46 +0.16 (+6.71%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends CERo Therapeutics (NASDAQ:CERO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$907,649.00 Get CERO Insider Trade Alerts Want to know when executives and insiders are buying or selling CERo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CERO Insider Buying and Selling by Quarter CERo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2024Bioventures Opportunities G YkMajor ShareholderSell29,989$6.00$179,934.00 12/11/2024Bioventures Opportunities G YkMajor ShareholderSell13,438$8.00$107,504.00 12/9/2024Bioventures Opportunities G YkMajor ShareholderSell8,505$11.00$93,555.00 12/6/2024Bioventures Opportunities G YkMajor ShareholderSell12,368$12.00$148,416.00 10/10/2024Bioventures Opportunities G YkMajor ShareholderSell32,500$10.00$325,000.00 9/25/2024Stuart M SloanMajor ShareholderSell5,324$10.00$53,240.00 (Data available from 1/1/2013 forward) CERO Insider Trading Activity - Frequently Asked Questions Who is on CERo Therapeutics's Insider Roster? The list of insiders at CERo Therapeutics includes Bioventures Opportunities G Yk, and Stuart M Sloan. Learn more on insiders at CERO. What percentage of CERo Therapeutics stock is owned by insiders? 18.00% of CERo Therapeutics stock is owned by insiders. Learn more on CERO's insider holdings. Which CERo Therapeutics insiders have been selling company stock? The following insiders have sold CERO shares in the last 24 months: Bioventures Opportunities G Yk ($854,409.00), and Stuart M Sloan ($53,240.00). How much insider selling is happening at CERo Therapeutics? Insiders have sold a total of 102,124 CERo Therapeutics shares in the last 24 months for a total of $907,649.00 sold. CERo Therapeutics Key ExecutivesDr. Daniel Mark Corey M.D. (Age 45)Founder, CTO & Director Compensation: $372.69kMr. Brian G. Atwood (Age 71)President, CEO & Chairman Mr. Charles Ross Carter (Age 56)CFO, Treasurer & Corporate Secretary Dr. Robert Sikorski M.D. (Age 61)Ph.D., Consultant More Insider Trading Tools from MarketBeat Related Companies MIRA Pharmaceuticals Insider Transactions Aprea Therapeutics Insider Transactions Cyclo Therapeutics Insider Transactions Bullfrog AI Insider Transactions BioXcel Therapeutics Insider Transactions Pieris Pharmaceuticals Insider Transactions MEI Pharma Insider Transactions Finch Therapeutics Group Insider Transactions NKGen Biotech Insider Transactions BriaCell Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:CERO) was last updated on 1/21/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
